Evidence map›Paper›PMID 39196420›Full record

ArticleEuropean child & adolescent psychiatry2025

Reply: the inclusion of methylphenidate in the WHO list of essential medicines is endorsed by millions of people with ADHD.

Samuele Cortese, David Coghill, Joerg M Fegert, Gregory W Mattingly, Luis A Rohde, Ian C K Wong, Stephen V Faraone

Abstract readLetter
PubMed Publisher
In one paragraph

Article in European child & adolescent psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Samuele CorteseCenter for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Highfield Campus, Building 44, Southampton, SO17 1BJ, UK. samuele.cortese@soton.ac.uk.
David CoghillDepartments of Paediatrics and Psychiatry, University of Melbourne, Melbourne, Australia.
Joerg M FegertKlinik für Kinder- und Jugendpsychiatrie / Psychotherapie, Universitatsklinikum Ulm, Ulm, Germany.
Gregory W MattinglyCenter for Neuroscience, Feinstein Institute for Medical Research, Manhasset, NY, USA.
Luis A RohdeAttention Deficit/Hyperactivity Program and Developmental Psychiatry Program, Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Ian C K WongCentre for Safe Medication Practice and Research Department of Pharmacology and Pharmacy Li Ka Shing Faculty of Medicine, The University of Hong, Hong Kong, China.
Stephen V FaraoneDepartment of Psychiatry and Behavioral Sciences, Norton College of Medicine at SUNY Upstate Medical University, Syracuse, NY, USA.

Funding

National Institute for Health and Care Research NIHR303122
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39196420

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.